ScreenHER

Advancing Early Detection

We Can Detect Cancer Early. So Why Are We Still Missing It?

We can detect cancer earlier than ever before.
But too often, we still miss the moment to act.

Many cancers, including cervical cancer, are highly survivable when detected and treated early. Yet despite this, cervical cancer remains the fourth leading cause of cancer death in women worldwide.

Early cancer detection isn’t just a science problem. It’s a systems problem.

We’ve made remarkable progress in detecting cancer risk—from HPV testing to advanced molecular diagnostics and at-home sampling. But outcomes are not determined by detection alone.

They are determined by whether patients can move through the system of care successfully. 

A patient sitting on an examination table in a medical office, wearing a blue hospital gown with legs crossed, next to a small stool.

When the System Becomes the Barrier

Consider Anne, a working mother of two in the U.S. Midwest.

She’s not uninsured. She’s not disengaged from her health. She has a stable job, a home, and a routine life—the kind of patient the system is designed to serve.

But her local hospital closed its OB/GYN services.

Now, specialist care requires a 90-minute drive each way.

Anne has already tested positive for high-risk HPV. She knows how she got it—after her husband’s infidelity—and it’s something she carries quietly, something she doesn’t want to explain or relive.

Over the past two years, she’s done everything she was told:

  • repeat testing
  • two rounds of biopsies
  • weeks of waiting for lab results

Each step has taken something from her:

  • time away from work and family
  • financial cost
  • emotional energy
  • a growing sense of uncertainty

The biopsies were painful. The waiting was worse.

She’s been told to come back again.

But what Anne needs now isn’t another test.

She needs resolution.

Clarity. A definitive answer. A path forward.

Instead, she’s caught in a cycle that feels invasive, prolonged, and exposed—without delivering the certainty she needs to act.

So she hesitates.

Not because she doesn’t believe in early detection—she does.
But because the system has asked too much, for too long, without giving her what she needs most.

She decides she’ll deal with it next year.

And that’s how early detection becomes late.


A Different Reality: Grace in Kenya

Now consider Grace, a mother of three living outside Nairobi.

Screening is technically available—but not easily.

The nearest clinic offering cervical cancer screening may be hours away. When she goes, she can wait most of the day to be seen. If testing is performed, she is often asked to return weeks later for results.

But returning isn’t simple.

Even when subsidized, screening and transport can cost the equivalent of several days’ income, and specialist care is typically concentrated in urban centers—financially out of reach for many.

So Grace makes a calculation.

Returning means:

  • losing income
  • paying for transportation again
  • finding care for her children
  • stepping away from everything that keeps her household running

So like many women, she delays.

Not because she doesn’t understand the risk—but because the system requires more than she can give.

In Kenya, most cervical cancer cases are diagnosed at advanced stages, when treatment is more difficult and outcomes are worse.

Grace doesn’t need more awareness.

She needs a system that works for her.

For Grace, it means access to answers and immediate next actions in a single visit—enabling treatment and a path toward resolution early, instead of discovery too late.


Detection Isn’t Enough Without Follow-Through

Modern screening methods are effective at identifying risk. But they rarely provide immediate, actionable answers.

Instead, they initiate a process:

Test → Wait → Follow-up → Retest → Referral → Biopsy

This pathway assumes that patients can:

  • return multiple times
  • navigate delays
  • absorb uncertainty
  • stay engaged over time

In reality, many cannot.

Loss to follow-up is not a patient failure.
It’s a system design failure.


The Hidden Cost of Friction

Every additional step introduces friction:

  • delays between testing and results
  • additional appointments and travel
  • administrative complexity
  • emotional burden

For Anne, friction looks like distance, cost, and emotional fatigue.
For Grace, it looks like access, affordability, and impossibility.

Different contexts. Same outcome:
missed opportunities for early detection—and delayed paths to resolution.


Rethinking the Future of Diagnostics

The next evolution in early detection isn’t just about better science.

It’s about better systems.

What if:

  • results were available in minutes, not weeks?
  • testing and decision-making happened in the same visit?
  • patients could move directly from detection to action?

This is the shift from detection to actionable detection—from identifying risk to enabling real-time decisions that change outcomes.


Designing for Real Life

Healthcare innovation often focuses on what’s technically possible.

But the real question is:
What works in the context of people’s lives?

For Anne, it means fewer visits, less invasiveness, and a clear path to resolution.
For Grace, it means answers and action in a single visit—without the burden of coming back again and again.

Because when care requires perfect follow-through, outcomes become dependent on everything going right.

And too often, it doesn’t.


Why ScreenHER

At ScreenHER, we believe early detection should do more than identify risk.

It should enable action.
It should deliver clarity.
And it should create a path to resolution—early, not late.

We are developing rapid, non-invasive diagnostics designed to deliver answers and immediate next actions at the point of care—reducing delays, minimizing loss to follow-up, and enabling same-visit decisions.

Because no woman—whether in the Midwest or in Kenya—should have to navigate a system that delays answers, prolongs uncertainty, or makes care harder to access.

Early detection only works if it leads to action.

And action only matters if it comes in time.


The Future of Early Detection

The future of cancer detection isn’t just more advanced.

It’s more:

  • Immediate
  • Actionable
  • Accessible
  • Aligned with real-world care

Because the goal isn’t just to detect disease.

It’s to ensure that every woman has the ability to act—quickly, confidently, and in time to change the outcome.


About the author

Jennifer Estep, Founder and CEO, ScreenHER

Jennifer Estep is the Founder & CEO of ScreenHER, a women’s health diagnostics company advancing rapid, non-invasive, point-of-care solutions for early cancer detection. A mechanical engineer with a background in medtech commercialization, she is focused on redesigning screening to deliver faster answers, enable timely action, and improve outcomes for women globally.


This is the third in a series on rapid diagnostics and early cancer detection. The first post, “Rapid Diagnostics: The Future of Women’s Cancer Detection Is Already Here,” and second post, “Rapid Diagnostics for Early Cancer Detection,” can be found here: https://screen-her.com/insights/

Discover more from ScreenHER

Subscribe now to keep reading and get access to the full archive.

Continue reading